4//SEC Filing
Hallen Ed 4
Accession 0001470831-25-000217
CIK 0001835830other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:40 PM ET
Size
10.1 KB
Accession
0001470831-25-000217
Insider Transaction Report
Form 4
Klaviyo, Inc.KVYO
Hallen Ed
Director10% Owner
Transactions
- Gift
Series A Common Stock
2025-09-15−20,260→ 702,216 total(indirect: By LLC) - Sale
Series A Common Stock
2025-09-15$31.65/sh−22,224$703,390→ 177,776 total(indirect: By Trust) - Sale
Series A Common Stock
2025-09-15$31.73/sh−67,524$2,142,537→ 722,476 total(indirect: By LLC)
Footnotes (6)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.07 to $31.965 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Shares are owned directly by Hodgkins Trust for the benefit of the Reporting Person and the Reporting Person's family, and of which the trustee is an independent institution. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.15 to $31.98 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Shares held by Hodgkins LLC, of which the Reporting Person serves as manager. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F6]Represents a bona fide gift of 20,260 shares of stock from the Reporting Person to a donor-advised fund pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
Documents
Issuer
Klaviyo, Inc.
CIK 0001835830
Entity typeother
Related Parties
1- filerCIK 0001991125
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:40 PM ET
- Size
- 10.1 KB